Eye Plastics Clinical Trials
To learn more about clinical trials on treatments for eye disease please call or email the contact for the specific study below.
For a longer list of studies needing volunteers throughout the U-M Health System, please go to UMClinicalStudies.
On this page:
There are currently no studies in this section.
Title: A multicenter, double-masked, placebo-controlled, efficacy and safety study of RV 001, an insulin-like growth factor-1 receptor (IGF-1R) antagonist antibody (fully human), administered every 3 weeks by intravenous (IV) infusion in patients suffering from active thyroid eye disease (TED)
IRB Number: HUM00073174
People with thyroid eye disease (TED) experience eye problems often due to an overactive thyroid (Grave’s disease). The eye problems seen with TED include swelling, redness, and discomfort of the eyelids and eye surface, increase tearing, thickening and pulling back of the eyelids, bulging of the eyes, squints, and double vision. TED can threaten sight for a small portion of patients. The purpose of this study is to obtain information on the safety and effectiveness of an investigational drug called RV 001 in the treatment of TED.